SCOPUS 정보 검색 플랫폼

Current Opinion in Oncology

Volumn 12, Issue 3, 2000, Pages 255-259

Bladder cancer

(2) Özen, Haluk a Hall, M Craig b

a HACETTEPE UNIVERSITY (Turkey)

b WAKE FOREST BAPTIST HEALTH (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; FIBRIN DEGRADATION PRODUCT; PROTEIN P21; PROTEIN P53; TELOMERASE; TUMOR ANTIGEN; TUMOR MARKER; VASCULOTROPIN;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER RESEARCH; HIGH RISK PATIENT; HUMAN; METASTASIS POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REPRODUCIBILITY; REVIEW;

CHEMISTRY, CLINICAL; GENETIC MARKERS; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0034525851 PISSN: 10408746 EISSN: None Source Type: Journal
DOI: 10.1097/00001622-200005000-00012 Document Type: Review

Times cited : (32)

References (16)

1
- 0033006836
- Cancer statistics, 1999
- (1999) CA Cancer J Clin , vol.9 , pp. 8-31
- Landis, S.H.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

2
- 0032892452
- Bladder cancer
- (1999) Curr Opin Oncol , vol.11 , pp. 207-212
- Ozen, H.¹

3
- 0033072805
- Noninvasive detection of bladder cancer with the BTA Stat test
- (1999) J Urol , vol.161 , pp. 443-446
- Pode, D.¹ Shapiro, A.² Wald, M.³ Nativ, O.⁴ Lauter, M.⁵ Kaver, I.⁶

4
- 0032830261
- The relationship between serial measurements of the level of a bladder tumor associated antigen and the potential for tumor recurrence
- (1999) J Urol , vol.161 , pp. 57-61
- Blumenstein, B.A.¹ Ellis, W.J.² Ishak, L.M.³

5
- 0032826253
- NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer
- (1999) J Urol , vol.161 , pp. 62-65
- Zippe, C.¹ Pandrangi, L.² Agarwal, A.³

6
- 0032863391
- Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA-Stat
- (1999) J Urol , vol.162 , pp. 53-57
- Sharma, S.¹ Zippe, C.D.² Pandrangi, L.³ Nelson, D.⁴ Agarwal, A.⁵

7
- 0031791985
- Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: Experience on 137 patients
- (1998) Urology , vol.52 , pp. 793-796
- Serreta, V.¹ Presti, D.L.² Vasile, P.³ Gange, E.⁴ Esposito, E.⁵ Menozzi, I.⁶

8
- 0032780343
- Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA-stat test in the diagnosis of transitional cell carcinoma of the bladder
- (1999) Eur Urol , vol.36 , pp. 225-229
- Sozen, S.¹ Biri, H.² Sinik, Z.³ Kupeli, B.⁴ Alkibay, T.⁵ Bozkirli, I.⁶

9
- 0033074324
- Comparison of screening methods in the detection of bladder cancer
- (1999) J Urol , vol.161 , pp. 388-394
- Ramakumar, S.¹ Bhuiyan, J.² Besse, J.A.³ Roberts, S.G.⁴ Wollan, P.C.⁵ Blute, M.L.⁶ O'Kane, D.J.⁷

10
- 0032325110
- Cytokeratin-20: A new marker for early detection of bladder carcinoma
- (1998) J Urol , vol.160 , pp. 1971-1974
- Buchumensky, V.¹ Klein, A.² Zemer, R.³ Kessler, O.J.⁴ Zimlichman, S.⁵ Nissenkorn, I.⁶

11
- 0032874431
- Immunocyt. A new tool for detecting transitional cell cancer of the urinary tract
- (1999) J Urol , vol.161 , pp. 1486-1489
- Mian, C.¹ Pycha, A.² Wiener, H.³ Haltel, A.⁴ Lodde, M.⁵ Marberger, M.⁶

12
- 0032854988
- Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates
- (1999) J Urol , vol.161 , pp. 799-804
- Crew, J.P.¹ O'Brien, T.² Bicknell, R.³ Fuggle, S.⁴ Cranston, D.⁵ Harris, A.L.⁶

13
- 0032941162
- Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urethelial cancer
- (1999) Urology , vol.53 , pp. 302-307
- Miyake, H.¹ Isao, H.² Yamanaka, K.³ Gohji, K.⁴ Arakawa, S.⁵ Kamidono, S.⁶

14
- 0032825985
- p53 mutations in bladder tumors inactivate the transactivation of the p21 and bax genes, and have a predictive value for the clinical outcome after Bacillus Calmette-Guerin therapy
- (1999) J Urol , vol.162 , pp. 69-73
- Pfister, C.¹ Flaman, J.M.² Dunet, F.³ Grise, P.⁴ Frebourg, T.⁵

15
- 0032877579
- Correlation and prognostic significance of p53, p21 and Ki-76 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy
- (1999) J Urol , vol.161 , pp. 792-798
- Zlotta, A.R.¹ Noel, J.-C.² Fayt, I.³ Drowart, A.⁴ Van Vooren, J.-P.⁵ Simon, J.⁶ Schulman, C.C.⁷

16
- 0032851546
- Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder
- (1999) J Urol , vol.162 , pp. 931-935
- Li, S.M.¹ Zhang, Z.² Chan, S.³ Mclenan, O.⁴ Dixon, C.⁵ Taneja, S.⁶ Lepor, H.⁷ Sun, T.⁸ Wu, X.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.